Skip to content
Dose Brief
Menu
No. 502 here · Grade C

Oak review

A desk that advertises flat, all-doses-one-price GLP-1 care — with nine different starting figures live at once, a term attached to none of them, and a Terms page that contradicts the two things its marketing promises loudest.

Visit Oak Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning
Tirzepatide
$300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning
Coverage
Coverage not published
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior reading— Re-read twice on 15 August 2026 with a real browser and no form input, and the figures MOVED BETWEEN THE TWO READS. In the morning its order form showed $200/mo for compounded semaglutide and $250 for tirzepatide; that afternoon, same URL, same entry path, browser storage cleared as a control, it showed $250 and $300 with the strike-throughs gone and every brand line $100 higher. What is stable is WHERE the price is: on the first screen of its order form, before a single question. The tracker previously carried no figure because the ladder was believed to be behind a 29-question intake — it is not, it is in front of it. What remains true is that Oak advertises nine different "starting" prices at once — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — attaches a term to none, and that its headline "$133 / $199" is the three-month prepay under code OAKSAVE200, billed upfront.

The scorecard

Oak scored on our six Brief Score factors. See the methodology.

Price Stability38/100
Supply Reliability44/100
Transparency34/100
Access Breadth52/100
Clinical Oversight44/100
Track Record50/100

What we like

  • Flat dose pricing is Oak's own headline claim — "One price · All dosages", "All doses are the same price" — which, if it holds, means a 0.25 mg starter pays the same as someone at 2.4 mg, the single most useful promise a desk can make to anyone who will titrate
  • A genuine non-injectable route: /weightloss sells sublingual drops and tablets alongside the injections, and /employers itemises oral tirzepatide separately, so readers who will not inject have somewhere to go
  • Both molecules are offered, and an employer lane exists for readers whose access might come through work rather than cash-pay
  • A 29-question health intake is a real clinical screen rather than the two-question formality several desks in this ranking use
  • Cancellation is self-serve, through the prescription page or by deleting the account, and stops future renewals
  • Clean against FDA's warning-letter index under the brand, the domain and all four operating names its own documents use, screened 8 August 2026 with a passing positive control

The caveats

  • Nine different "starting" figures are live on the site simultaneously — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and not one page attaches a term or a billing cadence to any of them, so there is no number on this desk a reader can plan around
  • The two cheapest of those, $119 and $185, appear only beside a "$200 off — new patient offer", and Oak's own affiliate page spells the structure out as "$50 off your first month, $200 off 3-months" — a three-month package discount. Its own undiscounted floors are $190/month and $167/mo
  • Its marketing and its contract disagree on the two things the marketing promises loudest. Three pages say "Membership Fees: None" and "No subscriptions"; the Terms say patients are charged a membership fee for a provider consult, and that most prescriptions are configured as a subscription that renews on a recurring basis against the card on file
  • We could not confirm the flat-dose claim. Oak advertises "All doses are the same price", while this desk's reading of its checkout copy on 7 August 2026 recorded the opposite — that each dose step costs roughly $50 to $75 more. Treat the flat claim as Oak's, unverified
  • Its advertising and its order form disagree: none of the nine "starting" figures Oak markets is the $200/$250 it actually charges, so anyone comparing it on the advertised numbers is comparing against a price it does not offer
  • Its own documents name three different operating entities — Oak Longevity Holdings Corp, Leaf Longevity Holdings Corp DBA Oak Longevity, and OAKLOVESYOU LLC — with the privacy policy listing Canada as its country
  • Neither the dispensing pharmacy nor any prescriber is named: only "Oak's contracted pharmacies" and "independent licensed physicians and nurse practitioners contracted through Oak's medical group partners", with no NPI published anywhere
  • No list of states served is published; the consent language says only "if and when permitted by state law"
  • The link we publish lands mid-funnel, at step 1 of 5, on an Oak-versus-competitors comparison table rather than a homepage — so the first prices a reader sees are a marketing claim with no term attached rather than anything they can buy
  • Withdrawing consent after a prescription has been issued and sent to a pharmacy does not cancel or reverse that prescription, per Oak's own Terms

The brief

Best for: Readers weighing Oak specifically who want to know what it does and does not publish before handing over 29 questions' worth of medical history — not readers trying to compare a price today. A desk that advertises flat, all-doses-one-price GLP-1 care — with nine different starting figures live at once, a term attached to none of them, and a Terms page that contradicts the two things its marketing promises loudest.

Ranked #502 of 509 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Visit Oak

Closest here

The desks scoring nearest Oak — the realistic shortlist if you're weighing it.

Weighing Oak against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs Oak, and every desk that outranks it is listed on the Oak alternatives ranking.

More desks we track (24)

478 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect Oak's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Oak's site. Not medical advice; see our disclosure.

← Back to all rankings